348 related articles for article (PubMed ID: 19048593)
1. [Treatment of post-transplant glomerulonephritis].
Sandrini S; Valerio F
G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
3. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
Cravedi P
G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine treatment of glomerular diseases.
Klein M; Radhakrishnan J; Appel G
Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant recurrence of primary glomerulonephritis.
Ponticelli C; Glassock RJ
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2363-72. PubMed ID: 21030574
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous immunoglobulins in the treatment of glomerulopathies].
Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M
G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502
[TBL] [Abstract][Full Text] [Related]
9. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
[TBL] [Abstract][Full Text] [Related]
10. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis.
Requião-Moura LR; Moscoso-Solorzano GT; Franco MF; Ozaki KS; Pacheco-Silva A; Kirsztajn GM; Câmara NO
Clin Transplant; 2007; 21(3):363-70. PubMed ID: 17488386
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
16. Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.
Damodar A; Mustafa R; Bhatnagar J; Panesar M; Gundroo A; Zachariah M; Blessios G; Tornatore K; Weber-Shrikant E; Venuto R
Clin Transplant; 2011; 25(3):375-9. PubMed ID: 20384712
[TBL] [Abstract][Full Text] [Related]
17. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
Murakami C; Manoharan P; Carter-Monroe N; Geetha D
Transpl Int; 2013 Dec; 26(12):1225-31. PubMed ID: 24118474
[TBL] [Abstract][Full Text] [Related]
19. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
20. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
